PRAX vs UTHR · $7.38B cap vs P/E 20, rev $1.56B
Praxis Precision Medicines Inc (PRAX) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
PRAX currently screens at market cap $7.38B. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the PRAX and UTHR stock pages for the full models.
Not investment advice.